Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Distinct thresholds govern Myc's biological output in vivo.

Murphy DJ, Junttila MR, Pouyet L, Karnezis A, Shchors K, Bui DA, Brown-Swigart L, Johnson L, Evan GI.

Cancer Cell. 2008 Dec 9;14(6):447-57. doi: 10.1016/j.ccr.2008.10.018.

2.

c-myc in the hematopoietic lineage is crucial for its angiogenic function in the mouse embryo.

He C, Hu H, Braren R, Fong SY, Trumpp A, Carlson TR, Wang RA.

Development. 2008 Aug;135(14):2467-77. doi: 10.1242/dev.020131. Epub 2008 Jun 11.

3.

Etiology-dependent molecular mechanisms in human hepatocarcinogenesis.

Schlaeger C, Longerich T, Schiller C, Bewerunge P, Mehrabi A, Toedt G, Kleeff J, Ehemann V, Eils R, Lichter P, Schirmacher P, Radlwimmer B.

Hepatology. 2008 Feb;47(2):511-20.

PMID:
18161050
4.

Variable expression of Cre recombinase transgenes precludes reliable prediction of tissue-specific gene disruption by tail-biopsy genotyping.

Schulz TJ, Glaubitz M, Kuhlow D, Thierbach R, Birringer M, Steinberg P, Pfeiffer AF, Ristow M.

PLoS One. 2007 Oct 10;2(10):e1013.

5.

WNT/beta-catenin signaling in liver health and disease.

Thompson MD, Monga SP.

Hepatology. 2007 May;45(5):1298-305. Review.

PMID:
17464972
7.

Conditional deletion of c-myc does not impair liver regeneration.

Li F, Xiang Y, Potter J, Dinavahi R, Dang CV, Lee LA.

Cancer Res. 2006 Jun 1;66(11):5608-12.

9.

Coordinated regulation of c-Myc and Max in rat liver development.

Sanders JA, Gruppuso PA.

Am J Physiol Gastrointest Liver Physiol. 2006 Jan;290(1):G145-55. Epub 2005 Sep 8.

10.

c-Myc is required for the formation of intestinal crypts but dispensable for homeostasis of the adult intestinal epithelium.

Bettess MD, Dubois N, Murphy MJ, Dubey C, Roger C, Robine S, Trumpp A.

Mol Cell Biol. 2005 Sep;25(17):7868-78.

11.
12.

Liver-specific pRB loss results in ectopic cell cycle entry and aberrant ploidy.

Mayhew CN, Bosco EE, Fox SR, Okaya T, Tarapore P, Schwemberger SJ, Babcock GF, Lentsch AB, Fukasawa K, Knudsen ES.

Cancer Res. 2005 Jun 1;65(11):4568-77.

13.

c-Myc regulates cell size and ploidy but is not essential for postnatal proliferation in liver.

Baena E, Gandarillas A, Vallespinós M, Zanet J, Bachs O, Redondo C, Fabregat I, Martinez-A C, de Alborán IM.

Proc Natl Acad Sci U S A. 2005 May 17;102(20):7286-91. Epub 2005 Apr 27.

14.

Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancer.

Calvisi DF, Thorgeirsson SS.

Toxicol Pathol. 2005;33(1):181-4. Review.

PMID:
15805070
15.

Endogenous Myc controls mammalian epidermal cell size, hyperproliferation, endoreplication and stem cell amplification.

Zanet J, Pibre S, Jacquet C, Ramirez A, de Alborán IM, Gandarillas A.

J Cell Sci. 2005 Apr 15;118(Pt 8):1693-704. Epub 2005 Mar 29.

16.

Nucleolar localization of hepatic c-Myc: a potential mechanism for c-Myc regulation.

Sanders JA, Gruppuso PA.

Biochim Biophys Acta. 2005 Mar 22;1743(1-2):141-50.

17.

Inactivation of TGF-beta signaling in hepatocytes results in an increased proliferative response after partial hepatectomy.

Romero-Gallo J, Sozmen EG, Chytil A, Russell WE, Whitehead R, Parks WT, Holdren MS, Her MF, Gautam S, Magnuson M, Moses HL, Grady WM.

Oncogene. 2005 Apr 21;24(18):3028-41.

PMID:
15735717
18.

c-myc overexpression in hepatocarcinogenesis.

Feitelson MA.

Hum Pathol. 2004 Nov;35(11):1299-302. No abstract available.

PMID:
15668885
19.

c-Myc as a therapeutic target in cancer.

Prochownik EV.

Expert Rev Anticancer Ther. 2004 Apr;4(2):289-302. Review.

PMID:
15056059
20.

c-Myc-deficient B lymphocytes are resistant to spontaneous and induced cell death.

de Alborán IM, Baena E, Martinez-A C.

Cell Death Differ. 2004 Jan;11(1):61-8. Erratum in: Cell Death Differ. 2004 Jun;11(6):690.

Supplemental Content

Support Center